We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boehringer Ingelheim, Teva Sued Over Aggrenox Pay-for-Delay Agreement
The item has been added to your shopping cart.
Boehringer Ingelheim, Teva Sued Over Aggrenox Pay-for-Delay Agreement
A California prosecutor is suing Boehringer Ingelheim and a Teva subsidiary, saying their $120 million agreement to push back the release of a generic Aggrenox blood thinner illegally delayed market competition for over seven years.